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Abstract 
In order to prevent biofilm formation by Candida albicans, several cationic peptides were 
covalently bound to polydimethylsiloxane. The salivary peptide Histatin 5 and two synthetic 
variants (Dhvar 4 and Dhvar 5) were used to prepare  peptide functionalized PDMS using 4-
azido-2,3,5,6-tetrafluoro-benzoic acid (AFB) as an interlinkage molecule. In addition, 5 
polylysine-, polyarginine- and polyhistidine-PDMS surfaces were prepared.   Dhvar 4 
functionalized PDMS yielded the highest reduction of the number of C. albicans biofilm cells 
in the Modified Robbins Device. Amino acid analysis demonstrated that the amount of 
peptide immobilized on the modified disks was in the nanomole range. Poly-D-lysine PDMS, 
in particular the homopeptides with low molecular weight (2,500 and 9,600) showed the 10 
highest activity against C. albicans biofilms, with reductions of 93 % and 91 %, respectively. 
The results indicate that the reductions are peptide dependent. 
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Introduction 
Biofilm formation on medical devices is frequently associated with infections and in many 
cases removal of the medical device is the only option to combat them (Khardori and Yassien 
1995; Kadry et al 2009). Several approaches have already been evaluated to inhibit microbial 
biofilm formation on medical materials (Danese 2002; Von Eiff et al 2005). First, various 5 
materials have been passively coated  e.g. alkanethiols on gold (Hou et al 2007), fish protein 
coatings on glass or vinyl plastic coverslips (Vejborg and Klemm 2008) and diamond-like 
carbon on stainless steel (Raulio et al 2008). These passive coatings are not antimicrobially 
active but alter the physico-chemical properties of surfaces, so that micro-organism/substrate 
interactions are weakened or even prevented (Hetrick and Schoenfish 2006). However, their 10 
effectiveness is limited, due to adsorption of conditioning films, masking the functional 
groups (Hetrick and Schoenfish 2006). Secondly, coatings releasing antimicrobial compounds 
including antibiotics (Price et al 1996; Kwok et al 1999a, 1999b; Stigter et al 2004), silver 
ions (Dowling et al 2003) or silver nanoparticles and antiseptics (for a review see Von Eiff et 
al 2005) have been designed for use in intravenous polyurethane catheters and urinary 15 
catheters (Wu and Grainger 2006). A third series of surface modifications includes polymers 
with positively charged moieties such as quaternary ammonium or phosphonium groups at 
their surface. These substrates can be synthesized via copolymerization (Kenawy and 
Mahmoud 2003; Kenawy et al 2006; Kenawy et al 2007) or using photo- or plasma-induced 
graft polymerization (Hsiue et al 1998; De Smet et al., unpublished data).  Grafting results in 20 
the production of materials with altered surface properties without influencing the bulk 
properties (Pan et al 2003). 
Covalent binding of cationic peptides may be a useful approach to prevent microbial 
biofilm formation. Histatins are a family of naturally occurring, histidine-rich, low molecular 
weight peptides in human saliva (Helmerhorst et al 1997) and tear fluid (Jumblatt et al 2006). 25 
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Of these, histatin (Hst) 1, 3 and 5 are the most abundant peptides in saliva (De Smet and 
Contreras 2005). Hst 5, which is a peptide fragment derived from Hst 3, possesses the highest 
activity against Candida albicans and salivary concentrations range from 15 to 50 µM 
(Edgerton et al 1998). In the oral cavity, salivary peptides are believed to inhibit C. albicans 
overgrowth, thus offering a natural protection from oropharyngeal candidiasis. In addition, 5 
homodimerization of histatin-derived peptides showed an improved in vitro bactericidal 
activity against Staphylococcus aureus (Welling et al 2007). Dhvar 4 and Dhvar 5 are 
synthetic variants of the active domain of Hst 5 (Den Hertog et al 2004). Exposure of micro-
organisms to histatins results in leakage of intracellular components accompanied by a release 
of intracellular potassium and a decrease in the cellular ATP-level.  10 
In certain circumstances, disease states can diminish the body’s natural protective 
mechanisms against infection.  For example, malignant laryngeal tumors of the vocal cords in 
humans are removed by a total laryngectomy. For voice rehabilitation of laryngectomized 
patients, a voice prosthesis (VP) is placed between the trachea and the oesophagus 
(Kasperbauer and Thomas 2004). This VP is highly susceptible to colonization by micro-15 
organisms, particularly by Candida spp., growing in biofilms on the surface (Bauters et al 
2002; Elving et al 2002). Laryngectomized patients show a decreased salivary secretion as a 
side effect of radiation therapy, thus reducing the concentration of natural protective peptides 
(Rodrigues et al 2006). The release of antimycotics from buccal, bio-adhesive tablets has not 
been successful in preventing biofilm formation on VPs because of this reduced saliva 20 
secretion (Ameye et al 2005). In vitro studies have already focussed on the removal of mixed 
species biofilms by Dhvar 4 and 5 (Oosterhof et al 2003). However, the antibiofilm effect 
against C. albicans by peptides (applied by covalent binding, unlike by adsorption or dip 
coating) completely immobilized on silicone rubber has not been determined so far. 
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In the present study, the antifungal effect of three histatin-like antimicrobial peptides 
(Hst 5, Dhvar 4 and Dhvar 5) and several polylysine, polyarginine and polyhistidine 
homopolymers covalently bound to silicone was assessed against planktonic and sessile C. 
albicans cells.  
 5 
 
Materials and methods 
Materials 
Dhvar 4 and Dhvar 5 were synthesized at the Mousseron Institute (Montpellier, France). 
HEPES buffer, MES buffer, ethyl acetate, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 10 
hydrochloride (EDC), N-hydroxysuccinimide (NHS), acrylic acid (AA) and Hst5 were 
purchased from Sigma (St. Louis, MO, USA). Ethanol was obtained from Chem Lab 
(Zedelgem, Belgium). 4-azido-2,3,5,6-tetrafluorobenzoic acid (AFB) was purchased from 
Invitrogen (Carlsbad, CA, USA) and RBS 35 solution was purchased from Chemical Products 
(Brussels, Belgium). Dichloromethane was obtained from Acros Fine Chemicals (Geel, 15 
Belgium). All homopolymers were purchased from Sigma. They included seven poly-D-
lysine HBr salts (molecular weight distributions: 1,000-4,000; 4,000-15,000; 15,000-30,000; 
30,000-70,000; 70,000-150,000; 150,000-300,000 and > 300,000); four poly-L-lysine HBr 
salts (molecular weight distributions: 500-2,000; 1,000-5,000; ≥ 15,000 and 15,000-30,000); 
two poly-DL-lysine HBr salts (molecular weight distributions: 1,000-4,000; 25,000-40,000); 20 
three poly-L-arginine HCl salts (molecular weight distributions: 5,000-15,000; 15,000-70,000 
and > 70,000 ) and one poly-L-histidine HCl salt (molecular weight distribution: 5,000-
25,000). 
 
Polydimethylsiloxane (PDMS) production 25 
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Medical grade silicone rubber (Q7-4735, Dow Corning Corp., Midland, MI, USA) was 
prepared as described previously (Coenye et al 2008).  
 
Synthesis of PDMS functionalized with peptides   
To select the appropriate interlinkage molecule for covalent binding of peptides to PDMS, 5 
Dhvar 4 was bound onto the PDMS surface by grafting of AA or AFB. To initiate grafting of 
PAA onto PDMS, the surfaces were brought in contact with a benzophenone solution (5% 
[w/v] in ethanol). In a first approach, Dhvar 4 was coupled to the carboxylic groups of grafted 
AA using EDC as coupling reagent in combination with NHS. To this end, a stable activated 
ester on the PDMS surface was prepared by soaking the PAA-grafted PDMS surface for 4 h at 10 
room temperature in a solution of 1.76 mM EDC and 1.78 mM NHS, dissolved in MES-
buffer (pH 5.5). The surfaces were washed in MES-buffer for 24 h at 37°C. Finally the 
terminal amino group of Dhvar 4 was coupled onto the surface in HEPES buffer pH 8.5, 
resulting in covalent binding of Dhvar 4 onto PDMS. After a contact time of 48 h the peptide 
containing disks were rinsed in sterile MilliQ water and treated aseptically until use. 15 
The second approach to synthesize Dhvar 4-PDMS makes use of AFB. PDMS sheets 
were incubated in ethanol for 4 h, to remove the catalyst and subsequently cleaned in a 2 % 
(v/v) RBS solution. The sheets were incubated in a saturated AFB solution (5 mg/ml) 
prepared in dry ethyl acetate for 4 h, allowing AFB to adsorb onto the PDMS sheets. 
Afterwards the incubated sheets were dried under reduced pressure to remove ethyl acetate 20 
from the surface. The azido group of AFB readily reacts with methyl groups on the PDMS 
and both sides of the PDMS sheet were irradiated with UVC light (λ = 254 nm) for 5 min. 
Following polymerization, the surfaces were cleaned using dichloromethane to remove the 
non-reacted AFB. NHS esters were then synthesized by the reaction of the carboxylic group 
with EDC and NHS in MES-buffer pH 5.5 for 4 h at room temperature. The obtained surfaces 25 
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were cleaned in MES buffer for 24 h at 37°C. Finally, Dhvar 4 was coupled to the PDMS 
substrate as described above.  
For covalent binding of all other (homo)peptides, the coupling procedure with AFB 
was used. Peptide concentrations of 5 or 20 mg/ml and 1 or 5 mg/ml were used for Dhvar 4 
and Dhvar 5, respectively. The peptide concentration for covalent binding of Hst 5 was 0.5 5 
mg/ml. All homopolymers were bound to PDMS using a concentration of 5 mg/ml of the 
homopeptide. 
 
Characterization of modified PDMS surfaces  
The peptide modified PDMS surfaces were characterized using Attenuated Total Reflection-10 
Infrared spectroscopy (ATR-IR) and Attenuated Total Reflection-imaging (ATR-imaging) 
Attenuated Total Reflection-Infrared spectroscopy (ATR-IR) measurements on the 
modified PDMS surfaces were performed at room temperature using a Biorad 575C 
spectrometer. All spectra were recorded between 4000 cm-1 and 720 cm-1 at 2 cm-1 resolution. 
A single beam reference spectrum of a freshly cleaned diamond crystal was recorded before 15 
the measurements and used as the background spectrum. All spectra were normalized by the 
C-H bending band of the PDMS backbone located at 1259 cm-1. 
For Attenuated Total Reflection-imaging (ATR-imaging) the Spotlight 300 instrument 
(Perkin Elmer Life and Analytical Sciences, Waltham, MA, USA), was used. Samples of 1.5 
mm thickness were tightened between the sample stage and the Ge crystal. The Spotlight 20 
system was run with two scans per pixel and with a spectral resolution of 4 cm-1. The data 
collection software collects rectangular image areas of 100 µm by 100 µm (De Smet et al., 
unpublished data).  
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Amino acid analyses were carried out to determine the amount of cationic peptide 
bound to PDMS. To this end, the peptide modified PDMS disks were cut in two pieces and 
introduced in a vial for hydrolysis. The vials were loaded in a vessel filled with 200 µl 6N 
HCl and subsequently with argon, closed and incubated at 106°C for 24 h. The hydrolysed 
amino acids were washed from the polymer with 200 µl of MilliQ water. From this mixture, 5 5 
µl of sample was loaded on an automated Applied Biosystems amino acid analyzer using the 
phenylisothiocyanate chemistry. Each sample was measured in triplicate. 
.  
Strain and culture conditions 
 Candida albicans SC5314 (ATCC MYA-2879) was used throughout. The strain was 10 
maintained at -80°C using the Microbank storage system (Pro-Lab Diagnostics, Richmond 
Hill, ON, Canada). After thawing at room temperature, one bead was transferred to 10 ml of a 
sterile Sabouraud broth (Becton Dickinson Co, Franklin Lakes, NJ, USA) and the inoculated 
broth was incubated at 37°C for 24 h. From this suspension, a pure culture was obtained on 
Sabouraud Dextrose agar (SDA, (Becton Dickinson). To prepare overnight cultures, one or 15 
two isolated colonies of the pure culture were transferred to Sabouraud broth.  
 
Determination of the minimal inhibitory concentration 
The minimal inhibitory concentrations (MICs) were determined using LYM broth (5 mM 
KCl, 5.6 mM Na2HPO4, 0.5 mM MgSO4, 1.0 mM sodium citrate, 0.4 mg l-1 ZnCl2, 2.0 mg l-1 20 
FeCl3.6H2O, 0.1 mg l-1 CuSO4.5H2O, 0.1 mg l-1 MnSO4.H2O and 0.1 mg l-1 Na2B4O7.10H2O) 
according to Rothstein et al (2001). Glucose, an amino acid mixture, and a vitamin mixture 
were added as well according to the manufacturer’s instructions. Stock solutions of each 
peptide were  diluted (1:2). Of each dilution, two ml were transferred to the wells of a flat-
bottom 24-well microtiter plate (TPP, Trasadingen, Switzerland). A standardized cell 25 
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suspension was prepared as follows : overnight cultures were centrifuged and the cells of 
these freshly prepared overnight cultures were washed three times with and diluted in LYM 
broth to a concentration of 106 CFU ml-1. One hundred µl of these standardized cell 
suspensions, containing appr. 105 C. albicans cells per ml LYM broth, were added to each 
well. Prior to use, the bacterial suspensions were vigorously mixed using a vortex mixer. 5 
Following 24 h of incubation at 37°C, the growth was measured by determining the 
absorbance at 530 nm using a Wallac Victor2 (PerkinElmer Life and Analytical Sciences, 
Waltham, MA, USA) microtiter plate reader. The MICs for each peptide was defined as the 
lowest concentration resulting in a lack of visible growth. For the homopeptides, instead of 
LYM broth, Yeast Nitrogen Base (YNB) medium supplemented with 50 mM glucose was 10 
used. Each MIC test was carried out in triplicate. The following concentration ranges were 
tested : 125-0.12 µg/ml (Dhvar 4), 100-0.01 µg/ml (Dhvar 5), 850-0.001 µg/ml (Hst), 2500-
78 µg/ml (poly-DL-lysine) and 2500-1 µg/ml (poly-L-lysine, poly-DL-lysine and poly-L-
arginine). 
 15 
Biofilm growth in the MRD 
C. albicans biofilms were grown on PDMS disks in the Modified Robbins Device (MRD), as 
described previously (Coenye et al 2008). Prior to the determination of the antibiofilm effect, 
all the modified surfaces were rinsed in sterile saline (0.9% [w/v] sodium chloride solution). 
A flow system consisting of 6 custom made stainless steel Modified Robbins Devices 20 
(MRDs) was employed to allow C. albicans adhesion and subsequent biofilm formation. One 
such a device comprises six individual ports in a linear array along a channel of rectangular 
cross-section, having dimensions of 10.0 mm (width), 145.0 mm (length) and 3.5 mm (depth), 
respectively. Each port may hold a cylinder-shaped plug that serves as a substrate for biofilm 
development at the interior side of the MRD. These were placed in an aluminium heating 25 
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block to ensure a constant temperature of 37°C during biofilm growth. Prior to each run the 
tubing, the valves and the devices were cleaned with MilliQ water and finally autoclaved. The 
assembly of these different parts was carried out prior to sterilization. Two bottles containing 
the C. albicans inoculum suspension and the growth medium (YNB supplemented with 50 
mM glucose) were connected to the silicone tubing under aseptic conditions. The inoculum 5 
suspension was prepared using saline (0.9 % sodium chloride solution). To this end C. 
albicans overnight cultures were centrifuged at 4000 rpm for 4 min and the pelleted yeasts 
were washed with saline. The cells were subjected to three wash cycles and finally 
resuspended in saline. One ml aliquots were added to 99 ml saline containing bottles resulting 
in the inoculum suspensions. The growth medium was prepared by adding 6.7 g of Yeast 10 
Nitrogen Base (Becton Dickinson) and 9 g glucose to 100 ml of MilliQ water. This solution 
was sterilized by vacuum filtration through a 0.45 µm cellulose acetate membrane filter 
(Corning Incorporated, Corning, NY, USA) and was aseptically diluted (1:10) in sterile 
MilliQ water, resulting in a YNB solution with final glucose concentration of 50 mM. The 
tubing was mounted on top of a pump head in a peristaltic pump (Watson-Marlow 505S, 15 
Bredel, Wilmington, MA, USA). The setup of each device includes a bypass to allow rinsing 
of the silicone tubing with either inoculum suspension or growth medium at the inlet side and 
removal of entrapped air bubbles. First the inoculum suspension was pumped towards the 
MRDs in order to fill the interior side of the MRD. Once filled, the pump was switched off 
and the MRDs were clamped off using a clamp at the inlet and one at the outlet side. Each 20 
device was flipped over to allow planktonic C. albicans cells adhering to the disks. After 1 h, 
the MRDs were flipped back and the clamps were loosened. The pump was started to permit a 
flow of continuous growth passing over the colonized disks. Flow rate was set at 0.5 rpm 
(corresponding with 7.9 ml/h) and C. albicans biofilms were allowed to develop at 37°C for 
24 h.  25 
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After biofilm formation, the number of sessile C. albicans cells was determined by plating on 
SDA, as described previously (Coenye et al 2008).  To this end, the sessile C. albicans cells 
were harvested following 1 h of adhesion and 1 h of adhesion followed by 24 h of biofilm 
formation. The disks were aseptically recovered from the plug (MRD) and added to Sab. The 
cells were harvested  by 30 s of intensive mixing with a vortex (IKA® works, Inc., 5 
Wilmington, NC, USA) and 30 s of sonication (Bransonic® 3510, Soest, The Netherlands) 
three times. Finally the C. albicans cell suspensions were serially (1:10) diluted in Sab, one 
ml aliquots were transferred to petri dishes (Novolab, Geraardsbergen, België) and mixed 
with molten SDA (45°C). The plates were incubated at 37°C for 24 h, the number of colonies 
was counted and the number of colony forming units was calculated for all disks.  10 
 
 
Statistical analysis 
All cell counts were log transformed and data from the peptide modified disks were compared 
with those from the corresponding control disks. Analysis of variance with the Scheffe post 15 
hoc tests was performed using the SPSS 15.0 software package (SPSS Inc, Chicago, IL). 
Differences in biofilm cell counts between modified and control disks were considered 
significant when p<0.05. Correlation between molecular weight of peptides and MIC values 
was determined using Kendall’s tau test ; correlations were considered statistically significant 
if p < 0.05. 20 
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Results and Discussion 
 
Characterization of modified PDMS surfaces 
The distribution of the cationic peptides bound to the PDMS surface, studied by ATR-
Imaging was found to be homogeneous for both procedures, i.e. grafting of AA or AFB (see 5 
Figure 1 in Supplementary Data). However, after biofilm growth in the MRD visual 
inspection revealed a marked swelling (i.e. increase in surface area available for biofilm 
formation) of the AA grafted PDMS. In contrast, PDMS disks modified with AFB remained 
unchanged. This observation strongly indicates the need for the selection of the appropriate 
interlinkage molecules for covalent binding of antimicrobials on PDMS. For all further 10 
experiments, AFB was used as the interlinkage molecule.  
 
Antifungal effect on planktonic C. albicans cells 
The MIC of Dhvar 4, Dhvar 5 and Hst 5 for C. albicans SC5314 was 7 µM, 9 µM and 41 µM, 
respectively (Table 1). The MICs of poly-D-lysine, poly-L-lysine, poly-DL-lysine and poly-15 
L-arginine where inversely correlated with the molecular weight of each peptide (p<0.05) 
(Table 2).  
 
Antifungal  effect of salivary  peptides on sessile C. albicans cells 
Table 1 lists the percent reduction in sessile C. albicans cell numbers on PDMS 20 
functionalized with Dhvar 4, using AA and AFB as interlinkage molecules. The reduction for 
each type of modification and for each replicate was calculated with reference to the cell 
count on the peptide-free control PDMS disks. The cell counts on the unmodified disks 
ranged from 104 to 105 after 1 h of adhesion and from  106 to 107 following 1 h of adhesion 
and 24 h of biofilm formation. The results clearly show that the highest reductions in the 25 
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numbers of sessile C. albicans cells, both after adhesion and biofim development were 
obtained for Dhvar 4 containing surfaces, modified using AFB. Dhvar 5  and Hst 5 yielded 
reductions of 64 % and 72 % (p < 0.05). Although a 10-fold higher concentration was used in 
the procedure for covalent binding of Dhvar 5 compared to Hst 5, similar reductions were 
observed. Maximum reduction (95 %) was obtained on Dhvar 4-PDMS surfaces.  5 
Our results differ from those obtained by others, such as Oosterhof et al. (2003), who 
used an artificial throat (a biofilm model system similar to the MRD) to grow mixed species 
biofilms on intact Groningen button voice prostheses. They examined the biofilm eradication 
effect of the synthetic peptides, Dhvar 4 and Dhvar 5, applied by dip coating. After a 3-day 
growth period, mature biofilms were exposed 3 times a day to Dhvar 4 and Dhvar 5, dissolved 10 
in the salivary substitute Xialine in a final concentration of 4 mg per ml (well above the MIC). 
Dhvar 4 did not affect the number of bacteria and yeasts compared with the control 
prostheses. The highest reductions [78 % (bacteria) and 94 % (yeasts)] were obtained on VPs 
soaked in Dhvar 5 solutions, (Oosterhof et al  2003). This is unlike our own observations and 
may reflect the profound difference in activity between bound and free peptides. 15 
 
Antifungal  effect of homopeptides on sessile C. albicans cells 
Histatins reportedly have intracellular targets (mitochondria). Their effects on cytoplasmatic 
membranes are limited and permeabilization of the microbial membrane is a secondary effect 
rather than the primary cause of their antimicrobial activity (Ruissen et al 2001, 2002; Den 20 
Hertog et al 2005, Welling et al 2007). The most potent anti-Candida member of this family 
is Hst 5 and analysis of its sequence showed the presence of lysine and arginine residues 
(Helmerhorst et al 1997). Covalent binding of peptides only consisting of lysine, arginine and 
histidine residues might increase the anti-Candida effect on biofilms, as these cationic amino 
acids are believed to be partly responsible for the antifungal effect.  25 
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Poly-D-lysine PDMS with molecular weights of 2,500 or 9,600 and poly-DL-lysine 
PDMS (molecular weight of 32,800) yielded a significantly lower C. albicans sessile cell 
count than the controls, with reductions of 93 %, 91 % and 79 %, respectively (Table 2). 
However, covalent binding of poly-D-lysine moieties containing more lysine residues 
drastically decreased the antibiofilm activity. C. albicans biofilm formation on other 5 
substrates was hardly affected (Table 2). In addition, neither poly-L-arginine PDMS nor poly-
L-histidine PDMS affected C. albicans biofilm growth. These observations demonstrate that 
inhibition of C. albicans biofilm formation highly depends on the nature of the immobilized 
peptide, its molecular weight and its stereochemistry. 
 10 
 
Conclusions 
In the present study we have shown that salivary peptides and homopeptides can be bound to 
PDMS using preferably AFB as the interlinkage molecule. AA is less suitable as interlinkage 
molecule as it results in swelling of the PDMS after contact with aqueous media in the MRD. 15 
This  highlights the importance of the interlinkage molecule to be bound to PDMS.  
Although reductions of > 90 % (Dhvar 4 and low molecular weight poly-D-lysine) 
were obtained in an in vitro biofilm model system, it remains to be established if these would 
be sufficient for a prolonged, protective effect in vivo.   
 20 
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Table 1. Reduction in C. albicans biofilm cells grown in the MRD recovered from peptide grafted PDMS. 
Substrate  MIC (µM)  
Interlinkage 
molecule  
Time 
(h)  
Concentration 
(mg ml-1)  
Peptide 
amount 
(nmoles) 
 n  
Sessile cells 
PDMS (control)     
% 
reduction 
(mean ± 
SD) 
p-value 
              PDMS (control) 
Modified   
Dhvar 4-
PDMS  7  PAA  1  5  1  6  4.51 ± 0.26 4.51 ± 0.41 - - 
    AFB  1  5  1  6  4.51 ± 0.26 4.16 ± 0.18 55±12 NS 
    PAA  24  5  1  6  6.57 ± 0.49 7.16 ± 0.39 - - 
    AFB  24  5  1  6  6.57 ± 0.49 5.17 ± 0.45 96±3 <0.001 
Dhvar 5-
PDMS  9  AFB  24  1  ND  12  6.67 ± 0.29 6.80 ± 0.18 - - 
    AFB  24  5  2  12  6.63 ± 0.24 6.16 ± 0.21 66±22 <0.05 
Hst 5-
PDMS  41  AFB  24  0.5  0.8  12  6.80 ± 0.22 6.21 ± 0.26 74±17 <0.05 
 
n, number of disks tested; PAA, polyacrylic acid; AFB, azido tetrafluorobenzoate; PDMS, polydimethylsiloxane; ND : not determined;  
Concentration refers to the concentration in solution used for modification; the amount of peptide refers to total amount per disk; - : biofilm 
formation stimulated (i.e. cell counts on control disks lower than on modified disks) ; NS, not significant.. 5 
 21 
Table 2. Reduction in C. albicans biofilm cells grown in the MRD recovered from homopeptide grafted PDMS (using 5 mg ml-1 of petide and 
AFB as interlinkage molecule). 
Substrate Mol wt range Mol wt MIC (µM) m 
peptide 
amount 
(nmoles) 
n 
Sessile cells % reduction 
(mean ± SD) p-value 
       PDMS (control) Modified   
Poly-D-Lysine PDMS 1,000-4,000 2,500 500 17 31 12 6.76 ± 0.36 5.59 ± 0.38 93 ± 5 <0.01 
 4,000-15,000 9,600 130 66 50 11 6.67 ± 0.32 5.58 ± 0.56 91 ± 7 <0.05 
 15,000-30,000 27,200 46 186 34 12 6.67 ± 0.32 6.32 ± 0.54 55 ± 39 NS 
 30,000-70,000 40,600 31 278 55 11 6.67 ± 0.32 6.49 ± 0.37 34 ± 34 NS 
 70,000-150,000 150,000 8 1027 47 11 6.67 ± 0.32 6.41 ± 0.56 43 ± 40 NS 
 150,000-300,000 262,300 ND 1797 49 12 6.67 ± 0.32 6.46 ± 0.39 37 ± 43 NS 
 > 300,000 391,700 ND 2055 51 4 6.72 ± 0.37 6.70 ± 0.34 4 ± 66 NS 
Poly-L-Lysine PDMS 500-2,000 584 67 4 ND 6 7.15 ± 0.24 6.78 ± 0.25 56 ±27 NS 
 1,000-5,000 4,200 9 29 ND 5 7.15 ± 0.24 6.88 ± 0.38 45 ± 50 NS 
 ≥ 15,000 15,000 0.08 103 ND 6 7.15 ± 0.24 7.10 ± 0.27 12 ± 49 NS 
 15,000-30,000 24,000 0.13 164 ND 6 7.15 ± 0.24 6.73 ± 0.44 61 ± 53 NS 
Poly-DL-Lysine PDMS 1,000-4,000 4,000 10 27 ND 6 7.15 ± 0.24 6.97 ± 0.24 34 ± 29 NS 
 25,000-40,000 32,800 0.06 255 ND 6 7.15 ± 0.24 6.46 ± 0.34 79 ± 13 <0.01 
Poly-L-arginine PDMS 5,000-15,000 13,300 0.15 76 29 18 6.91 ± 0.33 6.84 ± 0.56 13 ± 72 NS 
 15,000-70,000 49,500 0.10 284 33 12 6.92 ± 0.35 7.04 ± 0.35 - - 
 > 70,000 125,000 0.08 718 42 12 6.92 ± 0.35 7.09 ± 0.28 - - 
Poly-L-histidine PDMS 5,000-25,000 10,000 ND 65 ND 6 6.91 ± 0.36 7.45 ± 0.18 - - 
 
m, number of amino acids per peptide; n, number of disks tested; AFB, azido tetrafluorobenzoate; PDMS, polydimethylsiloxane; Mol wt,  
molecular weight of most abundant molecule in mixture ; ND, not determined; peptide amount refers to total amount per disk; - : biofilm 5 
formation stimulated (i.e. cell counts on control disks lower than on modified disks) ; NS, not significant. 
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Supplementary data - Figure 1. ATR image of unmodified PDMS (top) and PDMS 
modified with Dhvar-4 using AFB as interlinker.  
